Role of peripheral nerve stimulation in treating chronic neuropathic pain: an international focused survey of pain medicine experts

被引:9
作者
Li, Alice Huai-Yu [1 ]
Bhatia, Anuj [2 ]
Gulati, Amit [3 ]
Ottestad, Einar [4 ]
机构
[1] Stanford Univ, Dept Anesthesia, Stanford, CA USA
[2] Univ Toronto, Dept Anesthesia & Pain Med, Toronto, ON, Canada
[3] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care, New York, NY USA
[4] Stanford Univ, Anesthesiol & Pain Med, Sch Med, Palo Alto, CA USA
关键词
pain management; peripheral nerve injuries; spinal cord stimulation; LOW-BACK-PAIN; MANAGEMENT; ALGORITHM; BURDEN; GUIDELINES;
D O I
10.1136/rapm-2022-104073
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Interventional pain management (IPM) options for refractory neuropathic pain (NP) have recently increased with availability of peripheral nerve stimulation (PNS) equipment and expertise. Given a lack of high-quality evidence and guidelines on this topic, we sought to understand the perception of physicians with expertise in treating NP regarding IPM and the role of PNS. We emailed a survey in March 2022 to international NP experts including pain medicine physicians, researchers, and leaders of 11 professional pain societies. No representatives from vendors of PNS systems were included in the design of the survey nor as respondents. Among 24 respondents (67% of those contacted), the distal common peroneal, tibial, and sural nerves were most frequently targeted (60%) with PNS. Persistent postsurgical pain of more than 3 months was the most common indication for PNS (84%). The aggregate NP treatment algorithm in order of median rank was non-opioid medications as first line, IPM including epidural/perineural steroid injections tied with transcutaneous electrical nerve stimulation as second line, pulsed radiofrequency (RF) tied with RF ablation/denervation as third line, temporary then permanent PNS as fourth line, followed by spinal cord stimulation, opioids, cryoablation, botulinum, peripheral nerve field stimulation, intrathecal targeted drug delivery, and others. Before offering PNS, 12 respondents (50%) indicated their preference for trialing non-neuromodulation treatments for 1-3 months. Twenty-two respondents (92%) agreed PNS should be offered early in the treatment of neuropathic pain. The most common barriers to PNS use were cost, lack of high-quality evidence in support of its use, lack of exposure to PNS in training programs, and lack of familiarity with the use of ultrasound guidance. PNS appears to have an increasing role in the treatment of NP but more research is needed on the outcomes of PNS to elucidate its role.
引用
收藏
页码:312 / 318
页数:7
相关论文
共 50 条
  • [1] Aló KM, 2011, PROG NEUROL SURG, V24, P41, DOI 10.1159/000323023
  • [2] A Comprehensive Algorithm for Management of Neuropathic Pain
    Bates, Daniel
    Schultheis, B. Carsten
    Hanes, Michael C.
    Jolly, Suneil M.
    Chakravarthy, Krishnan V.
    Deer, Timothy R.
    Levy, Robert M.
    Hunter, Corey W.
    [J]. PAIN MEDICINE, 2019, 20 : S2 - +
  • [3] Global burden of neuropathic pain
    Blyth, Fiona M.
    [J]. PAIN, 2018, 159 (03) : 614 - 617
  • [4] Review of Recent Advances in Peripheral Nerve Stimulation (PNS)
    Chakravarthy, Krishnan
    Nava, Andrew
    Christo, Paul J.
    Williams, Kayode
    [J]. CURRENT PAIN AND HEADACHE REPORTS, 2016, 20 (11)
  • [5] Implications of early and guideline adherent physical therapy for low back pain on utilization and costs
    Childs, John D.
    Fritz, Julie M.
    Wu, Samuel S.
    Flynn, Timothy W.
    Wainner, Robert S.
    Robertson, Eric K.
    Kim, Forest S.
    George, Steven Z.
    [J]. BMC HEALTH SERVICES RESEARCH, 2015, 15
  • [6] Epidural Steroids A Comprehensive, Evidence-Based Review
    Cohen, Steven P.
    Bicket, Mark C.
    Jamison, David
    Wilkinson, Indy
    Rathmell, James P.
    [J]. REGIONAL ANESTHESIA AND PAIN MEDICINE, 2013, 38 (03) : 175 - 200
  • [7] Neuropathic pain
    Colloca, Luana
    Ludman, Taylor
    Bouhassira, Didier
    Baron, Ralf
    Dickenson, AnthonyH.
    Yarnitsky, David
    Freeman, Roy
    Truini, Andrea
    Attal, Nadine
    Finnerup, Nanna B.
    Eccleston, Christopher
    Kalso, Eija
    Bennett, David L.
    Dworkin, RobertH.
    Raja, Srinivasa N.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2017, 3
  • [8] A Systematic Literature Review of Spine Neurostimulation Therapies for the Treatment of Pain
    Deer, Timothy R.
    Grider, Jay S.
    Lamer, Tim J.
    Pope, Jason E.
    Falowski, Steven
    Hunter, Corey W.
    Provenzano, David A.
    Slavin, Konstantin, V
    Russo, Marc
    Carayannopoulos, Alexios
    Shah, Jay M.
    Harned, Michael E.
    Hagedorn, Jonathan M.
    Bolash, Robert B.
    Arle, Jeff E.
    Kapural, Leo
    Amirdelfan, Kasra
    Jain, Sameer
    Liem, Liong
    Carlson, Jonathan D.
    Malinowski, Mark N.
    Bendel, Markus
    Yang, Ajax
    Aiyer, Rohit
    Valimahomed, Ali
    Antony, Ajay
    Craig, Justin
    Fishman, Michael A.
    Al-Kaisy, Adnan A.
    Christelis, Nick
    Rosenquist, Richard W.
    Levy, Robert M.
    Mekhail, Nagy
    [J]. PAIN MEDICINE, 2020, 21 (07) : 1421 - 1432
  • [9] The Neurostimulation Appropriateness Consensus Committee (NACC) Safety Guidelines for the Reduction of Severe Neurological Injury
    Deer, Timothy R.
    Lamer, Tim J.
    Pope, Jason E.
    Falowski, Steven M.
    Provenzano, David A.
    Slavin, Konstantin
    Golovac, Stanley
    Arle, Jeffrey
    Rosenow, Joshua M.
    Williams, Kayode
    McRoberts, Porter
    Narouze, Samer
    Eldabe, Sam
    Lad, Shivanand P.
    De Andres, Jose A.
    Buchser, Eric
    Rigoard, Philippe
    Levy, Robert M.
    Simpson, Brian
    Mekhail, Nagy
    [J]. NEUROMODULATION, 2017, 20 (01): : 15 - 30
  • [10] DeSantana Josimari M, 2008, Curr Rheumatol Rep, V10, P492